AKEBIA THERAPEUTICS INC (AKBA) Stock Balance Sheet
NASDAQ:AKBA • US00972D1054
Current stock price
1.43 USD
+0.01 (+0.7%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 184.84M | 51.87M | 42.92M | 90.50M | 149.80M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | 47.03M | 34.37M | 39.29M | 40.30M | 51.60M | |||
| Inventories | 15.61M | 16.24M | 15.69M | 21.60M | 36.60M | |||
| Other Current Assets | 5.47M | 11.35M | 20.24M | 32.90M | 33.10M | |||
| Total Current Assets | 252.96M | 113.83M | 118.15M | 185.20M | 271.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.88M | 10.42M | 16.05M | 34.40M | 40.60M | |||
| Goodwill | 59.04M | 59.04M | 59.04M | 59.00M | 59.00M | |||
| Intangibles | N/A | 0.00 | 36.04M | 72.10M | 108.10M | |||
| Other Non-Current Assets | 59.68M | 37.38M | 12.42M | 5.40M | 50.40M | |||
| Total Non-Current Assets | 123.61M | 106.84M | 123.55M | 170.90M | 258.20M | |||
| TOTAL ASSETS | 376.56M | 220.67M | 241.70M | 356.10M | 529.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 17.36M | 2.27M | 17.50M | 32.00M | 97.50M | |||
| Accrued Expenses | 121.72M | 63.46M | 67.73M | 75.80M | 109.00M | |||
| Accounts Payable | 21.18M | 15.18M | 14.63M | 18.00M | 33.60M | |||
| Other Current Liabilities | 2.68M | 2.27M | 0.00 | 3.70M | 20.90M | |||
| Total Current Liabilities | 162.94M | 80.91M | 99.87M | 129.50M | 261.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 176.21M | 175.47M | 111.29M | 34.10M | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Liabilities | 4.80M | 13.47M | 61.13M | 187.20M | 194.30M | |||
| Total Non-Current Liabilities | 181.02M | 188.94M | 172.42M | 221.30M | 194.20M | |||
| TOTAL LIABILITIES | 343.95M | 269.86M | 272.29M | 350.80M | 455.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.68B | -1.68B | -1.61B | -1.56B | -1.46B | |||
| Additional Paid In Capital | 1.72B | 1.63B | 1.58B | 1.56B | 1.54B | |||
| Common Shares | 2.00K | 2.00K | 2.00K | 0.00 | 0.00 | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 6.00K | 6.00K | 6.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 265.42M | 224.85M | 194.58M | 184.10M | 177.00M | |||
| Tangible Book Value per Share | -0.10 | -0.48 | -0.65 | -0.68 | -0.53 | |||
| Total Shareholders' Equity | 32.61M | -49.19M | -30.58M | 5.20M | 74.00M | |||
| TOTAL LIABILITIES AND EQUITY | 376.56M | 220.67M | 241.70M | 356.10M | 529.30M | |||
| Statistics | ||||||||
| Debt/Equity | 5.40 | -3.57 | -3.64 | 6.56 | N/A | |||
| Current Ratio | 1.55 | 1.41 | 1.18 | 1.43 | 1.04 | |||
| Return On Assets (ROA) | -1.42% | -31.45% | -21.48% | -26.45% | -53.28% | |||
| Return On Equity (ROE) | -16.39% | N/A | N/A | -1811.54% | -381.08% | |||
| Return On Invested Capital (ROIC) | 9.61% | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 71.36% | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21